Maintenance therapy in advanced non-small cell lung cancer.
about
First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients.Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell line.Maintenance therapy in NSCLC: why? To whom? Which agent?Approval summary: erlotinib maintenance therapy of advanced/metastatic non-small cell lung cancer (NSCLC)Erlotinib: as maintenance monotherapy in non-small-cell lung cancer.
P2860
Maintenance therapy in advanced non-small cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Maintenance therapy in advanced non-small cell lung cancer.
@ast
Maintenance therapy in advanced non-small cell lung cancer.
@en
Maintenance therapy in advanced non-small cell lung cancer.
@nl
type
label
Maintenance therapy in advanced non-small cell lung cancer.
@ast
Maintenance therapy in advanced non-small cell lung cancer.
@en
Maintenance therapy in advanced non-small cell lung cancer.
@nl
prefLabel
Maintenance therapy in advanced non-small cell lung cancer.
@ast
Maintenance therapy in advanced non-small cell lung cancer.
@en
Maintenance therapy in advanced non-small cell lung cancer.
@nl
P1476
Maintenance therapy in advanced non-small cell lung cancer.
@en
P2093
P304
P356
10.1097/JTO.0B013E3181D86E8B
P577
2010-05-01T00:00:00Z